Skip to content

[R-meta] What asymmetry test to use?

4 messages · Martin Lobo, Guido Schwarzer

#
Hello everyone. I am performing an analysis, and when doing the asymmetry tests I see totally different results.
How do I know which one I should use?
This is a meta-analysis of SMD, with a random model given the high herogenicity.
The classic Egger test gives a p of 0.0129 and the Egger test with mixed effects model p 0.1015.
 I post the results.
Regression Test for Funnel Plot Asymmetry

model:     weighted regression with multiplicative dispersion
predictor: standard error

test for funnel plot asymmetry: t = 2.7964, df = 16, p = 0.0129
Regression Test for Funnel Plot Asymmetry

model:     mixed-effects meta-regression model
predictor: standard error

test for funnel plot asymmetry: z = 1.6378, p = 0.1015

best regards



Lorenzo Mart?n Lobo MTSAC, FACC, FESC
Especialista Jerarquizado en Cardiolog?a
Jefe de Dpto Enf. Cardiovasculares y Cardiometabolismo Hospital Militar Campo de Mayo.
Jefe de Cardiolog?a Hospital Militar Campo de Mayo
Ex Jefe de Unidad Coronaria Hospital Militar Campo de Mayo
Miembro Titular de la Sociedad Argentina de Cardiolog?a
Fellow American College of Cardiology
Fellow European Society of Cardiology
Ex Miembro del Area de Investigaci?n de la SAC
Ex Director del Consejo de Aterosclerosis y Trombosis de la SAC
Miembro Asesor del Consejo de Aterosclerosis y Trombosis de la SAC
Ex Director del Consejo de Epidemiolog?a y Prevenci?n Cardiovascular de la SAC
Miembro Asesor del Consejo de Epidemiolog?a y Prevenci?n Cardiovascular de la SAC
Experto en Lipidos de la Sociedad Argentina de Lipidos.
Miembro de la Sociedad Argentina de Lipidos.
Instructor de ACLS de la American Heart Association
#
Martin,

We recently published the results of a simulation study evaluating the LFK index test (https://onlinelibrary.wiley.com/doi/10.1002/jrsm.1714). We compared this method with the classic Egger and Thompson-Sharp test (aka Egger test with mixed effects model). Our simulations were for meta-analyses with the mean difference but I guess they are useful for the SMD.

The Thompson-Sharp test was conservative under homogeneity but hold the significance level under heterogeneity. The Egger test was either too liberal or conservative under heterogeneity.

Accordingly, I would lean to rely on the results of the Thompson-Sharp test as you observe high heterogeneity.

This said, typically a significance level of 10 percent is recommended for tests of funnel plot asymmetry (Sterne et al., 2011, BMJ) and the p-value of the Thompson-Sharp test is just above this value.

Best,
Guido
#
Dear Guido, thank you so much for your answer.

I already downloaded the article to have it among my methodological appointments.

On the other hand, when I look at the funnel plot, if there seems to be a certain asymmetry.

Another question that always arises is whether the publication bias should be carried out for each sub-analysis or for the global analysis. That is, I analyzed the subgroups of drugs vs. placebo and drugs vs. other drugs. You should evaluate the bias of all included studies or that of each subgroup separately. The results I show are from the global analysis. I share a link to see the funnel plot.

<https://1drv.ms/i/s!Ao1t9qGYkJ0rpbYRQtPrNRyOfZVb9Q?e=fSf1yD>
[https://sat02pap003files.storage.live.com/y4mcubhS2neYbUqJenfbbFJjWLPITb8eyxCNO6IIYkB3iQWIHavTNo7A9wvUXCkFxxSrGH2l0-dzxbyMRTZzpM7DzLFYAlEwDOQoCtDUCA4_WSiq0KNG29_jkdguja2QNbMpe06jxOzzTOmKqrq1oVTZv5XBYUIrjkkKG9Gg3G5De0?width=200&height=150&cropmode=center]
[https://res-h3.public.cdn.office.net/assets/mail/file-icon/png/cloud_blue_16x16.png]Funnel Inflamacion 2.jpg


thanks for your time

Best regards




Lorenzo Mart?n Lobo MTSAC, FACC, FESC
Especialista Jerarquizado en Cardiolog?a
Jefe de Dpto Enf. Cardiovasculares y Cardiometabolismo Hospital Militar Campo de Mayo.
Jefe de Cardiolog?a Hospital Militar Campo de Mayo
Ex Jefe de Unidad Coronaria Hospital Militar Campo de Mayo
Miembro Titular de la Sociedad Argentina de Cardiolog?a
Fellow American College of Cardiology
Fellow European Society of Cardiology
Ex Miembro del Area de Investigaci?n de la SAC
Ex Director del Consejo de Aterosclerosis y Trombosis de la SAC
Miembro Asesor del Consejo de Aterosclerosis y Trombosis de la SAC
Ex Director del Consejo de Epidemiolog?a y Prevenci?n Cardiovascular de la SAC
Miembro Asesor del Consejo de Epidemiolog?a y Prevenci?n Cardiovascular de la SAC
Experto en Lipidos de la Sociedad Argentina de Lipidos.
Miembro de la Sociedad Argentina de Lipidos.
Instructor de ACLS de la American Heart Association
#
Martin,

The large between-study heterogeneity might be due to including both studies comparing drugs with placebo and drugs with other drugs. Furthermore, the (slight) asymmetry in your funnel plot might be due to between-study heterogeneity which was already described in the paper introducing the Egger test as a potential source of asymmetry (Egger et al., 1997, BMJ).

You could look at a funnel plot of studies comparing drugs with placebo. However, if drugs have a different efficacy, you might get an asymmetric funnel plot due to heterogeneity.

A funnel plot of drugs vs other drugs is not well defined as you might include studies comparing A vs B or B vs A (and similarly for any other drug comparison).

All this said, I would argue that your setting (studies comparing drugs with placebo and drugs with other drugs) calls for the conduct of a network meta-analysis. If you would go this route, the paper by Chaimani and Salanti (https://onlinelibrary.wiley.com/doi/10.1002/jrsm.57) gives a nice introduction into the evalution of small study effects in network meta-analysis and introduces the comparison-adjusted funnel plot.

Best,
Guido